BA.2.12.1 accounted for nearly 48 percent of all COVID-19 cases in the week ending May 14, up from 43 percent on May 7. The prevalence of BA.2, which became dominant in March, has fallen from 73 percent of cases for the week ending April 23 to 50.9 percent as of May 14.
Nationwide, COVID-19 cases and hospitalizations increased 61 percent and 27 percent, respectively, over the last 14 days as of May 18, according to HHS data tracked by The New York Times.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
